With the rapid decline cost of sequencing, it is now clinically affordable to examine multiple 14 genes in a single disease-targeted test using next generation sequencing. Current targeted 15 sequencing methods require a separate step of targeted capture enrichment during sample 16 preparation before sequencing, and the library preparation process is labor intensive and time 17 consuming. Here, we introduced an amplification-free Single Molecule Targeted Sequencing 18 (SMTS) technology, which combined targeted capture and sequencing in one step. We 19 demonstrated that this technology can detect low-frequency mutations of cancer genes. SMTS 20 has several advantages, namely that it requires little sample preparation and avoids biases and 21 errors introduced by PCR reaction. SMTS can be applied in cancer gene mutation detection, 22 inherited condition screening and noninvasive prenatal diagnosis.
Introduction 24
In the past few years, the cost of large-scale DNA sequencing has been dramatically driven down 25 by the tremendous advances in next-generation sequencing (NGS) 1 . Nonetheless, the cost of 26 human whole genome sequencing and bioinformatics interpretation is still significant. In clinical 27 practice, NGS is used to examine specific gene panels such as cancer genes and inherited 28 conditions, sample numbers are high and data volume per sample is relatively small. It is often 29 more cost-effective and time-efficient to target, capture, and sequence only the genomic regions 30 of interest 2 . For example, there are several cancer gene panels commercially available, targeting 31 as few as 50 to many hundreds of genes that are frequently mutated in cancer patients 3 . The 32 cancer gene panel targeted sequencing has been proved to be useful in hereditary cancers 33 diagnosis, and disease management. 34 Current NGS based targeted sequencing methods require a separate step of capture enrichment 35 during sample preparation before sequencing 4, 5 . The two most commonly used custom-capture 36 methods are based on hybridization or on highly multiplexed PCR. In the solution-based 37 hybridization method, biotinylated DNA or RNA complementary probes are designed bind to 38 gene targets, which are then purified using streptavidin-labeled magnetic beads. In the 39 multiplexed PCR method, hundreds or thousands of PCR primer pairs are mixed to amplify the 40 targeted genes. 41 In this report, we demonstrated a technology and platform to perform Single Molecule Targeted 42 Sequencing (SMTS), which combined targeted capture and sequencing in one step. We used a 43 combination of Total Internal Reflection Fluorescence (TIRF) microscope and single molecule 44 fluorescence dyes to reject unwanted background noise and get single molecule resolution 45 images 6 . The gene-specific flow cell was constructed with capture primers for gene regions of 46 interest and the target genes can thus be sequenced without copying the DNA or enrichment 47 before sequencing. Compared to current targeted sequencing methods with separate capture steps, 48 SMTS has significant advantages, including little sample preparation and avoidance of biases 49 and errors introduced by PCR amplification 7 . SMTS can be applied in cancer gene mutation 50 detection, inherited condition screening, and high-resolution human leukocyte antigen (HLA) 51 typing.
52

Results
53
Single molecule detection 54 The fundamental limitation of detection of single molecule fluorescence signals stems from the 55 intrinsic qualities of the fluorophore. The key challenge is to reduce the background interference, 56 which may arise from Raleigh scattering, Raman scattering, and contaminant fluorescence.
57
Various single-molecule fluorescence microscopy techniques have been developed in the last 58 two decades to overcome the difficulty in detecting single molecules with high signal to noise 59 ratios in the presence of optical background 8 . 60 We applied Total Internal Reflection Fluorescence (TIRF) microscopy in this study. The optical 61 setup is shown in Fig. 1 . When light strikes an interface going from coverslip glass to fluid in the 62 flow cell chamber at an angle greater than a critical angle, it undergoes a total internal reflection.
63
This generates an exponentially decaying light field called the "evanescent wave" above the The choice of fluorescent dyes to label nucleotides is also critical for single molecule detection.
72
Many common fluorescent labels show rather low photostability if high-intensity laser excitation
73 is used and processes are to be observed over long periods of time. We choose the ATTO 647N 74 dyes to label the nucleotides, which fluoresces twice as strong as cyanine 5 in aqueous solution. 75 Meanwhile, we optimized the imaging buffer to increase the photostability up to five times ( Fig.   76 S5).
77
Single-step photobleaching is used as a quality control to distinguish single molecule from 78 multiple molecules. In an ideal situation, each DNA molecule is separately binding to the flow 79 cell surfaces and the minimal distance between two DNA molecules is larger than the diffraction 80 limit of light. In a random attachment cenari(as used in the present study) drive by Poisson 81 statistics, two or more DNA molecules may bind to the surface at a distance less than the 2). We observed that 38% of spots are real single molecules, where 36% of spots are aggregated 86 molecules. Only the sequences from the real single molecule spots will be used for analysis.
87
Targeted hybridization and sequencing 88 The EGFR, KRAS, BRAF genes were selected for sequencing in this studies. In particular, we 89 aimed to sequence the 8 genetic variants that are related to drug response, including six point 90 mutations and two short deletions (Table 1) . Eight capture probe sequences were designed in the 91 upstream of drug response related mutations. The capture probes are synthesized and anchored to 92 the flow cell surface by a expoxy-NH2 bond. We synthesized two sets of target DNA templates 93 for sequencing. The first set was wild type sequence and the second set contained mutations and 94 short deletions (Table 1) . Each target DNA template contained a Cy3 fluorescence dye at the 3' 95 end. Excitation of 3' Cy3 fluorescent dyes was used to mark positions of annealed templates on 96 the flow cell surfaces. Synthetic target DNA templates were hybridized to the flow cell with 97 surface-attached capture probes (Fig 3a) .
98
The sequencing reaction began with locating the target DNA templates, which are randomly 99 hybridized to capture probes (Fig. 3a) . The Cy3 fluorescent dyes attached to target DNA were cleaved from the reversible terminators, and the system is ready for a second round of 112 adding reversible terminators and polymerases. The sequencing cycle are repeated many times to 113 achieve the desired length of read ( Fig. 3b ).
114
Sequencing coverage depth 115 To demonstrate the performance of SMTS, we sequenced the wild-type EGFR/KRAS/BRAF 116 DNA templates. The synthesized DNA templates were hybridized to the flow cell with surface-117 attached capture probes. We sequenced DNA for 19-30 cycles, which enable to cover all 118 mutation/deletion loci. 300 fields of view were imaged for each cycle. In each field of view, 119 there are approximate 2200-2500 reads on average. The sequencing reads were aligned to 120 reference sequences with customized program of Smith-Waterman algorithm ( Table 2 ). We 121 observed that the coverage depth varies among different DNA templates ( Figure 4a ). The 122 possible explanation is that the hybridization efficiency for DNA templates is sequence-123 dependent and the secondary structures that involve the target region can also affect 124 hybridization efficiency. The average coverage depth was 1954-fold. Higher coverage depth can 125 be achieved by capturing images for more fields of view.
126
Sequencing accuracy 127 The accuracy was calculated by comparing the reference sequences with the consensus 128 sequences. Consensus sequences were calculated as the most frequent bases at each position in 129 the sequence alignment (Table 2) . By comparing the consensus sequence to the reference 130 sequence base-by-base, the consensus sequence is 100% identical to the reference sequence in 131 our four repeated experiments. We performed sampling-subsampling to the sequence data to get 132 low-coverage data, and recalculated the consensus sequences at different coverage depth. If each 133 base was covered only one time, which means the coverage depth is 1 fold, the accuracy was 95% 134 on average. If each base was covered with 5 times or more on average, the consensus accuracy is 135 approaching 100% accuracy ( Fig. 4c ). We performed multiple repeated experiments to estimate 136 the errors in the raw sequencing data. The reads from each template were separately aligned to 137 the DNA reference. Each position in the reference was mapped by multiple reads. The error rate 138 of a position was the ratio of reads disagreeing with the reference divided by the total number of 139 reads mapped to the reference. The overall error rate was an average of error rate of all positions.
140
The error of raw sequencing reads was dominated by deletion ( Fig. 4b ). The substitution error is Detecting low frequency of mutations 144 The wild type DNA was mixed with mutant type DNA at 10:1 and 97:3 ratios (Table 1) . The
145
DNA mixture was hybridized to the flow cell and sequenced. Each raw sequence read was 146 aligned to reference sequences to determine whether it originated from wild type or mutant type 147 DNA. As a control, we also sequenced pure wild type DNA with the same condition. We found 148 that the percentage of mutant DNA detected in the DNA mixture was significantly higher than 149 that in pure wild type DNA control (Fig. 5 ). In this experiment, SMTS can detect mutant 150 sequences with frequency 3%.
151
Discussion
152
We here demonstrated a method of capturing and sequencing DNA in a single step, which 153 provides a much simpler approach to targeted sequencing. We have shown that the mutations 154 and short deletions can be accurately detected at low frequency. 155 We have included several mutations of EGFR/KRAS/BRAF genes in this study. These mutations We observed that the coverage depth was not uniform among different positions. Some 175 sequences appeared to be difficult to be sequenced. The uniformity of coverage could be 176 improved by carefully designing the capture probes, in particularly, to avoid the secondary 177 structure. We also observed that only one third of fluorescence spots were from single molecules.
178
Under the random attachment scenario described in this study, a large portion of spots came from 179 two or more molecules binding closer than the diffraction limited resolution of the system. The with the same fluorescence dye. In future, we can modify the reversible terminators and label 187 each of four nucleotides with unique fluorescence dyes 15 . By doing so, the speed and accuracy 188 will be improved.
189
For the foreseeable future, the high cost and complexity of data analysis will limit the application 190 of whole-genome sequencing for the detection of mutations in a clinical setting. Targeted 191 resequencing of areas of interest will therefore remain key to determining mutational status.
192
SMTS is a stride forward in putting this into practice. Although currently only a few loci of a 193 few genes are screened, there is clearly scope for the creation of multi-gene capture arrays, 194 allowing large numbers of loci to be analyzed rapidly and cost-effectively with low DNA input 195 requirements. The single-step capturing and sequencing whole exome is also possible in future.
196
In its simplicity, this approach provides an opportunity to truly begin integrating the vast 197 quantity of genomic data generated in this next-generation era with clinical practice. Mä nnedorf, Swiss) to drive the fluidic in the system by suction.
217
Surface chemistry 218 Synthesized capture probes (oligonucleotides) were covalently coupled to the epoxy coated 219 coverslip surface. The capture probes were firstly incubated at 95°C, then the coverslip was 220 immerged into a capture probe solution at 1 nM in 150mM K 2 HPO4, pH 8.5 at 37°C for 2 hours.
221
Then the coverslip was rinsed by 3X SSC with 0.1% Triton X-100 and 3X SSC, 150mM 222 K 2 HPO4, pH 8.5 in sequence.
223
Imaging processing 224 Images are processed using a custom written spot localization algorithm (Fig. S4) . Firstly, stage 225 drifts between different imaging cycles were corrected by calculating the peak position of two The coverslip was incubated in synthesized templates labeled with Cy3 solution at 5nM in 3X 261 SSC, pH7, at 55 °C for 2 hours to form a DNA duplex. Then the surface was rinsed with 150mM 262 HEPES, 1X SSC and 0.1% SDS, followed by 150mM HEPES and 150mM NaCl. Finally the 263 coverslip was assembled into the follow cell.
264
The sequencing process was controlled automatically by the fluidic system. Two different types 265 of reagents containing nine pre-prepared reagents were used and stored at different temperatures. 266 One type is the chemical or biochemical reaction reagents, including four nucleotide (dNTP- Quality control on the sequence reads was first performed. Firstly, reads with length less than 5 285 bases were filtered out. Then, sequencing reads that appeared less than 4 times were filtered out. 286 Secondly, sequencing reads that could not be aligned to reference sequences are not included for 287 further analysis.
288
The alignment described above was performed with Smith-Waterman algorithm, which performs 289 local sequence alignment. By using a custom definition scoring system (which included the 290 substitution matrix and the gap-scoring scheme), the chosen algorithm could guarantee 291 identification find of the optimal local alignment. In this setup, the penalty for a deletion in a 292 read was -1, for an insertion -1, for a match 2, and for a substitution -2. cycles, imaging and base calling. We traced a part of one field of view in multiple sequencing cycles. In 370 the beginning, the image of Cy3 green fluorescence dyes were used to locate the position of target 371
templates. Three positions were circled out and were traced. In the first cycle, reversible terminators A 372 (nucleotide analogs) were flowed in for reaction. Position 2 and 3 successfully incorporated a base. In the 373 second cycle, the reversible terminators T were flowed in for reaction. Position 1 and 2 successfully 374 incorporated a base. The sequencing continued and the sequence of DNA template extended. The 375
sequence of each DNA template in position 1, 2 and 3 can be reconstructed. 376 377   Table 1 . The capture probe and target DNA sequence information. The top block is the capture probe 378 sequences we synthesized. The capture probes were designed to capture EGFR/KRAS/BRAF genes. The 379 middle block is the target DNA sequence designed for testing. These sequences are design based on the 380 wild type of EGFR/KRAS/BRAF genes. Nucleotide bases in red color are drug related mutation sites.
381
The bottom block is the target DNA sequence designed based on the mutant type. 382 15 383 384 Table 2 . Sequencing alignment of raw reads. The top row is the reference sequence. Insertion errors 385
were not shown in the alignment. 100:0, 10:1 and 97:3 ratios. The mixed DNA was subjected to sequencing. Each sequence reads was 396 aligned to the wild type and mutant type reference sequences and alignment scores were calculated. If the 397 alignment score of wild type reference sequence was higher than that of mutant type reference sequence, 398 the original sequence read was classified as wild type. Otherwise, it was classified as mutant type. The 399 frequency of wild type and mutant type sequence reads are calculated for each reference. (a-c) The 400 frequency of wild type and mutant type sequences calculated from the sequencing data. (d), The average 401 of mutant sequences in sequencing data over all template sequences. P value is calculated by two-tailed 402
Student T test. 403
